Sugi Predict

Sugi Predict / Compounds / SCHEMBL410463

SCHEMBL410463

SCHEMBL410463

Cc1ccc(C2(c3ccc(C)cc3O)OS(=O)(=O)c3ccccc32)c(O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.67
▸ ALDH1A1 P00352 3/20 0.67
▸ CYP3A4 P08684 2/20 0.67
▸ MAPK1 P28482 1/20 0.67
▸ CDK2 P24941 1/20 0.60
▸ PTPN11 Q06124 2/20 0.59
▸ LMNA P02545 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ HIF1A Q16665 1/20 0.55
▸ TRPA1 O75762 1/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ POLB P06746 2/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4634262 0.99 TDP1 (0.65) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL16285462 0.85 MEN1 (0.66) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL5936692 0.83 ALDH1A1 (0.56) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL12218631 0.82 ALDH1A1 (0.54) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL16303147 0.81 TDP1 (0.68) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL62880 0.80 CYP3A4 (1.00) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL220836 0.80 TDP1 (0.71) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL29369363 0.80 TDP1 (0.71) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL29446745 0.80 CYP3A4 (1.00) TDP1ALDH1A1CYP3A4MAPK1CDK2
SCHEMBL10976762 0.79 ALDH1A1 (0.52) TDP1ALDH1A1CYP3A4MAPK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9316594-B2 Carbon dioxide (CO2) sensor POLESTAR TECHNOLOGIES, INC. (US) 2016-04-19 — — US claimed
US-20130323845-A1 CARBON DIOXIDE (CO2) SENSOR POLESTAR TECHNOLOGIES, INC. 2013-12-05 — — US claimed
CN-101173901-A N-acet-beta-amino glucosidase diagnostic reagent kit and method for measuring active concentration of N-acet-beta-amino glucosidase SUZHOU ANJ BIOTECH CO LTD (CN) 2008-05-07 — — CN claimed
US-6825040-B2 APPARTUS FOR USE IN THE DETECTION OF ACIDS IN SAMPLE MAINSTREAM ENGINEERING CORPORATION 2004-11-30 — — US claimed
US-20030087451-A1 Acid test kit MAINSTREAM ENGINEERING CORP. 2003-05-08 — — US claimed
US-5881879-A System for preserving and delivering gas-containing solutions BAXTER INTERNATIONAL INC. (US) 1999-03-16 — — US claimed
US-5403744-A Colorimetric analysis using metachromatic dye, pH indicator dye, polyelectrolytes with anionic sites to bind with dyes; for testing urine, blood MILES INC. (US) 1995-04-04 — — US claimed
US-5143023-A Animal litter with chemically bound chemical indicators KLEANHEART, INC. (US) 1992-09-01 — — US claimed
US-4376162-A ORGANIC SILVER SALT, PHOTOCATALYST, REDUCING AGENT FUJI PHOTO FILM CO., LTD. (JP) 1983-03-08 — — US claimed
US-11952324-B2 Amidoamine synthesis, methods to track the reaction process SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2024-04-09 — — US disclosed
US-20210323909-A1 Amidoamine Synthesis, Methods to Track The Reaction Process SCHLUMBERGER TECHNOLOGY CORPORATION 2021-10-21 — — US disclosed
EP-3662033-A1 AMIDOAMINE SYNTHESIS, METHODS TO TRACK THE REACTION PROCESS M.I L.L, C. (US) 2020-06-10 — — EP disclosed
EP-2091322-B1 CLUMP RECOGNITION ANIMAL LITTER CHURCH & DWIGHT CO INC (US) 2019-08-14 — — EP disclosed
EP-1994385-B1 CHANGED CONDITION INDICATOR COOPERMAN ISADORE (US) 2019-08-14 — — EP disclosed
US-4433139-A N-Acetyl-β-D-glucosamnides for determining N-acetyl-β-D-glucosaminidase activity SHIONOGI & CO., LTD. (JP) 1984-02-21 — — US disclosed
US-4376162-A ORGANIC SILVER SALT, PHOTOCATALYST, REDUCING AGENT FUJI PHOTO FILM CO., LTD. (JP) 1983-03-08 — — US disclosed
EP-0060793-A1 N-acetyl-beta-D-glucosaminides for determining N-acetyl-beta-D-glucosaminidase activity SHIONOGI & CO., LTD. (JP) 1982-09-22 — — EP disclosed
US-RE30267-E SEMIPERMEABLE MEMBRANE, THIN FILM EASTMAN KODAK COMPANY (US) 1980-05-06 — — US disclosed
US-4066403-A DECOMPOSITION, PERMEABLE BARRIERS EASTMAN KODAK COMPANY (US) 1978-01-03 — — US disclosed
US-3974041-A Image recording member with zeolitic water containing compounds CANON KABUSHIKI KAISHA (JA) 1976-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11952324-B2 Amidoamine synthesis, methods to track the reaction process FAR1, NAAA, FFAR2 TDP1 3501/4885ALDH1A1 1232/4885CYP3A4 652/4885
US-20210323909-A1 Amidoamine Synthesis, Methods to Track The Reaction Process FAR1, NAAA, FFAR2 TDP1 3501/4885ALDH1A1 1232/4885CYP3A4 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.